simethicone 180 MG Oral Capsule [Phazyme]

RxNorm concept 352091, branded drug (sbd). Prescribable name: PhaZyme Ultra Strength 180 MG Oral Capsule.

RxCUI: 352091
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/352091 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

simethicone 9796

Other names

Phazyme 180 MG Oral Capsule

Related concepts

simethicone 180 MG (SCDC, consists of)
simethicone 180 MG [Phazyme] (SBDC, consists of)
Oral Capsule (DF, has dose form)
Phazyme (BN, has ingredient)
simethicone 180 MG Oral Capsule (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 352091 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/352091 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 352091. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.